ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Salt Lake City, UT, USA:

Abemaciclib and Letrozole to Treat Endometrial Cancer

letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...

Active, not recruiting
Endometrial Cancer
Drug: Letrozole
Drug: Abemaciclib

Phase 2

Gynecologic Oncology Group (GOG)

Salt Lake City, Utah, United States and 28 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Doxorubicin
Drug: Paclitaxel

Phase 3

Eisai
Eisai

Salt Lake City, Utah, United States and 168 other locations

This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors...

Enrolling
Hormone Receptor-positive/Her2 Negative Breast Cancer
High Grade Serous Ovarian Cancer
Drug: PRO1184 intravenous infusion of PRO1184
Drug: PRO1184

Phase 1, Phase 2

Genmab
Genmab

West Valley City, Utah, United States of America and 31 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Diagnostic Test: OncoSignature
Drug: ACR-368

Phase 1, Phase 2

Acrivon Therapeutics

Salt Lake City, Utah, United States and 66 other locations

and antitumor activity of PRO1107 in patients with advanced solid tumors. This study consists of 2 parts, Part A: dose escalation and dose l...

Enrolling
Endometrial Cancer
Non-small Cell Lung Cancer
Drug: PRO1107

Phase 1, Phase 2

Genmab
Genmab

Salt Lake City, Utah, United States and 3 other locations

preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...

Enrolling
Solid Tumor
Ovarian Neoplasms
Drug: NKT3447

Phase 1

NiKang Therapeutics

West Valley City, Utah, United States of America and 7 other locations

The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.

Enrolling
Endometrial Cancer
Breast Cancer
Drug: Pembrolizumab
Drug: IDE-161

Phase 1

Ideaya Biosciences

West Valley City, Utah, United States of America and 22 other locations

The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. ...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: TOS-358

Phase 1

Totus Medicines

West Valley City, Utah, United States and 15 other locations

Locations recently updated

The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...

Enrolling
Uterine Cervical Neoplasms
Ovarian Neoplasms
Drug: LY4170156

Phase 1

Lilly
Lilly

West Valley City, Utah, United States of America and 14 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Salt Lake City, Utah, United States and 123 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems